News

Aurinia Pharmaceuticals Inc. announced that the Company has initiated a Rolling Submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for…
Read More...

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug…
Read More...

AcelRx Pharmaceuticals announced the execution of a definitive merger agreement to acquire Tetraphase Pharmaceuticals, Inc. (Tetraphase) in a stock for stock deal at an exchange ratio…
Read More...

Regeneron Pharmaceuticals and Sanofi announced they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection. Kevzara is a…
Read More...

XORTX Therapeutics Inc. a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late stage clinical programs, announces that it…
Read More...

BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft.,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced an update from the Phase III JAVELIN Head and Neck 100 study…
Read More...

Thermo Fisher Scientific announced it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion…
Read More...

Eurofins announces that two of its clinical diagnostic testing laboratories in the United States now offer testing for evaluation of COVID-19. On 13 March 2020, Viracor Eurofins, one of…
Read More...

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with…
Read More...

Tyligand Bioscience, Ltd. and Context Therapeutics LLC announced the signing of collaboration agreements for the manufacturing, registration and future commercialization of onapristone…
Read More...

AbCellera and Eli Lilly and Company announced they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease caused by the…
Read More...

Vir Biotechnology, Inc. announced that it has signed a letter of intent with Biogen Inc. (Nasdaq: BIIB) for the development and clinical manufacturing of human monoclonal antibodies for…
Read More...

Emergent BioSolutions Inc. announced that it has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19). These product…
Read More...

NICE has today (12 March 2020) published final draft guidance which recommends fremanezumab (also called Ajovy and made by Teva Pharmaceuticals) for preventing chronic migraine. The…
Read More...

Harbour BioMed (HBM) announced successful completion of its Series B+ round financing of $75 million to accelerate the advancement of its clinical-stage compounds and growing portfolio…
Read More...

Kuur Therapeutics announced the launch of its new business in partnership with Baylor College of Medicine and Baylor’s Center for Cell and Gene Therapy. Houston-based Kuur Therapeutics…
Read More...

Bristol Myers Squibb Company announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug…
Read More...

WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy, and Cognate BioServices, Inc., a leading contract development…
Read More...

Chime Biologics announced operations as an independent and stand-alone Biologics CDMO company. With the separation from JHL Biotech complete, Chime Biologics is now focused on…
Read More...